NicOx is developing NCX-701, a nitric oxide-releasing derivative of paracetamol (acetaminophen), for the potential treatment of inflammation and pain. The compound is currently undergoing phase III clinical trials.
|Original language||English (US)|
|Number of pages||5|
|Journal||Current Opinion in Investigational Drugs|
|State||Published - Jul 1 2004|
ASJC Scopus subject areas
- Drug Discovery